Washington Medicaid’s subscription-based payment model (SBPM) for hepatitis C virus (HCV) medications led to a 16.2% increase in HCV prescription fills. After Washington launched its SBPM with AbbVie Inc. for access to Mavyret in 2019, the number of HCV prescription fills for Mavyret translated to an estimated increase of 3.8 quarterly prescription fills per 100,000 Medicaid enrollees. Washington used a two-part pricing model for its five-year contract with AbbVie Inc. The state pays a reduced price per prescription through supplemental rebates up to a certain spending threshold. After hitting this threshold, the per . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options

Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!